• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
New Tool Lets You Search CDC Advisors’ Big Pharma Ties

New Tool Lets You Search CDC Advisors’ Big Pharma Ties

March 11, 2025
California’s New Senate Leader Gets Pressed On Oversight As Fraud Scrutiny Intensifies

California’s New Senate Leader Gets Pressed On Oversight As Fraud Scrutiny Intensifies

January 6, 2026
Socialist Blue City Mayor, Police Guild Butt Heads Over Whether Arresting Drug Users Is A Good Thing

Socialist Blue City Mayor, Police Guild Butt Heads Over Whether Arresting Drug Users Is A Good Thing

January 6, 2026
JD Vance Breaks Down The Latest On The Trump Administration’s Crackdown On Left-Wing Violence

JD Vance Breaks Down The Latest On The Trump Administration’s Crackdown On Left-Wing Violence

January 6, 2026
Jasmine Crockett Unloads on Supreme Court After Texas Map Ruling: ‘F— You’

Jasmine Crockett Unloads on Supreme Court After Texas Map Ruling: ‘F— You’

January 6, 2026
Somali Democrat Runs In Utah’s Brand New Deep Blue House Seat

Somali Democrat Runs In Utah’s Brand New Deep Blue House Seat

January 6, 2026
House Republican Pushes TPS Crackdown Amid Exploding Minnesota Welfare Fraud Probe

House Republican Pushes TPS Crackdown Amid Exploding Minnesota Welfare Fraud Probe

January 6, 2026
Tim Walz Refuses To Resign As He Faces Major Backlash For Somali Scandal

Tim Walz Refuses To Resign As He Faces Major Backlash For Somali Scandal

January 6, 2026
Zohran Mamdani Elected New York City’s First Muslim Mayor After Landslide Victory Over Cuomo

Mamdani Defends Tenant Chief Amid Firestorm

January 6, 2026
Here’s Who Could Potentially Replace Tim Walz As Minnesota Governor

Here’s Who Could Potentially Replace Tim Walz As Minnesota Governor

January 6, 2026
Vivek Ramaswamy Rage Quits Social Media After Being Bullied For Being Indian

Vivek Ramaswamy Rage Quits Social Media After Being Bullied For Being Indian

January 6, 2026
Majority Of Republicans Support Maduro Ouster — But Worry What Comes Next

Majority Of Republicans Support Maduro Ouster — But Worry What Comes Next

January 6, 2026
‘Get Your Children Out’: State Education Board Member Blasts System As Rotten And Corrupt By Design

‘Get Your Children Out’: State Education Board Member Blasts System As Rotten And Corrupt By Design

January 6, 2026
  • Donald Trump
  • Tariffs
  • Congress
  • Faith
  • Immigration
Tuesday, January 6, 2026
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

New Tool Lets You Search CDC Advisors’ Big Pharma Ties

by Daily Caller News Foundation
March 11, 2025 at 1:20 pm
in News, Wire
247 6
0
New Tool Lets You Search CDC Advisors’ Big Pharma Ties
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Daily Caller News Foundation

A new search tool unveiled Friday increases public access to information about the connections between advisors to the Centers for Disease Control and Prevention on vaccine policy and the pharmaceutical industry.

The Advisory Committee on Immunization Practices (ACIP) discusses epidemiological studies, weighs the benefits and side effects reported in clinical trials, and makes recommendations to the CDC on the routine vaccination schedules for children and adults. The ACIP’s recommendations inform which shots are reimbursed by health plans. In a bid to enhance transparency around the process, the Department of Health and Human Services (HHS) has enabled users to search which advisors reported potential conflicts of interest and recused themselves from casting a vote affecting a drugmaker they had ties to.

The new tool is consistent with pledges by HHS Secretary Robert F. Kennedy Jr. to restore trust and the nation’s health agencies lost during the pandemic through increased information.

“In alignment with HHS Secretary Kennedy’s commitment to radical transparency, CDC released a tool for Americans to easily access conflicts of interest for ACIP committee members,” a CDC spokesman said in an email. “Rather than conflicts of interest being buried within meeting minutes, this tool quickly provides the public with ACIP members’ conflicts of interest.”

The ACIP became a flashpoint for controversy during the COVID-19 pandemic, reenergizing concerns about payments advisors receive from the pharmaceutical industry.

Of the experts who have served on the ACIP from 2000 to 2024, 38 advisors reported potential conflicts of interest.

That number could amount to approximately one third of the individuals who have served on the ACIP since 2000, assuming the ACIP was always fully staffed and adjusting for the shifting number of maximum ACIP members spelled out in its charter over the years. But this percentage could be an underestimate. For example, ACIP currently only has 14 members of the maximum 19.

Reported connections between the advisors and pharma included a range of potential conflicts: honoraria for lectures, consulting fees, employment at academic institutions conducting studies with drugmakers, or direct collaboration with drugmakers on clinical trials.

Advisors are asked to disclose conflicts of interest at the beginning of each public meeting and prior to a vote, but were otherwise tricky to track before the new tool became available.

ACIP members are required to submit confidential financial disclosures annually and self-report conflicts of interest at the start of each meeting and vote. Conflicts of interest and perceived conflicts of interest are vetted by the CDC if necessary, according to the committee’s website. But special government employees receiving no salary are not required to make public financial disclosures.

Some scientists praised the ACIP tool.

“They are the gatekeepers. The vendors’ job is to bring products into the market. At the same time, the gatekeepers ensure the product’s safety, accuracy, and reliability before human use,” said Masfique Mehedi, associate professor of biomedical sciences at the University of North Dakota, in an email to the Daily Caller News Foundation.

By contrast, Paul Offit, director of the Vaccine Education Center and an attending physician at Children’s Hospital of Philadelphia, who served on the ACIP from 1998 to 2003, said in an interview with DCNF that the tool is reflective of Kennedy’s beliefs about the pharmaceutical industry and could decrease public trust in vaccines.

“It’s very easy to say Big Pharma is this monster capturing the FDA. I just don’t see that in the vaccine world,” Offit said.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].

Tags: DCNFinvestigative-groupU.S. News
Share196Tweet123
Daily Caller News Foundation

Daily Caller News Foundation

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Thanks for reading IJR

Create your free account or log in to continue reading

Please enter a valid email
Forgot password?

By providing your information, you are entitled to Independent Journal Review`s email news updates free of charge. You also agree to our Privacy Policy and newsletter email usage

No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th